Prospects for therapy of HIV-associated neurologic diseases.
Sacktor
N
N
Johns Hopkins University, Department of Neurology, Baltimore, MD 21287, USA.
McArthur
J
J
D015526:AIDS Dementia Complex / Q000209:etiology / Q000628:therapy; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000379:methods / Q000592:standards; D015331:Cohort Studies; D016207:Cytokines / Q000502:physiology; D003586:Cytomegalovirus Infections / Q000150:complications / Q000628:therapy; D018792:Encephalitis, Viral / Q000150:complications / Q000628:therapy; D015658:HIV Infections / Q000150:complications* / Q000628:therapy; D006801:Humans; D007167:Immunotherapy; D007968:Leukoencephalopathy, Progressive Multifocal / Q000150:complications / Q000628:therapy; D009422:Nervous System Diseases / Q000150:complications / Q000453:epidemiology / Q000628:therapy*; D018696:Neuroprotective Agents / Q000627:therapeutic use; D009483:Neuropsychological Tests; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced / Q000150:complications / Q000628:therapy
D019380:Anti-HIV Agents; D016207:Cytokines; D018696:Neuroprotective Agents